What are Nitroimidazole antiparasitic drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nitroimidazole antiparasitic drugs are pharmacologic agents that share a common mechanism (typically targeting Trypanosoma cruzi DNA and cellular proteins). 0 are currently marketed, with 2 more in clinical development.

Nitroimidazole antiparasitic

0 marketed 2 in Phase 3

This page covers all Nitroimidazole antiparasitic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Trypanosoma cruzi DNA and cellular proteins, Trypanosoma cruzi DNA and proteins.

Targets

Trypanosoma cruzi DNA and cellular proteins · Trypanosoma cruzi DNA and proteins

Phase 3 pipeline (2)

Short regimen of benznidazole · Laboratorio Elea Phoenix S.A. · Infectious Disease / Parasitology
Benznidazole is a nitroimidazole antiparasitic that generates reactive metabolites to damage the DNA and cellular structures of Trypanosoma cruzi parasites.
Short treatment with benznidazole · Laboratorio Elea Phoenix S.A. · Infectious Disease / Parasitology
Benznidazole is a nitroimidazole antiparasitic that generates reactive metabolites to damage the DNA and proteins of Trypanosoma cruzi, the parasite causing Chagas disease.

Patent intelligence

nitroimidazole antiparasitic patent landscape — aggregated cliff calendar, attackable patents, originator estates